Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Pronova planning IPO

Pronova (Lysaker, Norway) plans to sell 25 million shares at NOK23-NOK29 in an

Read the full 134 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE